Arteris, Inc. (NASDAQ:AIP) Short Interest Down 23.3% in November

Arteris, Inc. (NASDAQ:AIP - Get Free Report) saw a significant decrease in short interest in November. As of November 30th, there was short interest totalling 391,100 shares, a decrease of 23.3% from the November 15th total of 509,900 shares. Based on an average trading volume of 111,700 shares, the short-interest ratio is presently 3.5 days. Approximately 1.6% of the company's shares are short sold.

Insider Transactions at Arteris

In other Arteris news, Director Isabelle F. Geday sold 15,550 shares of the business's stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $9.03, for a total value of $140,416.50. Following the transaction, the director now owns 121,213 shares in the company, valued at $1,094,553.39. The trade was a 11.37 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Nicholas B. Hawkins sold 19,299 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $8.14, for a total transaction of $157,093.86. Following the completion of the transaction, the chief financial officer now directly owns 192,414 shares of the company's stock, valued at approximately $1,566,249.96. The trade was a 9.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 92,717 shares of company stock valued at $791,369 over the last 90 days. Corporate insiders own 33.70% of the company's stock.

Institutional Trading of Arteris

Several hedge funds have recently bought and sold shares of AIP. Vanguard Group Inc. increased its holdings in shares of Arteris by 0.3% during the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company's stock valued at $8,390,000 after purchasing an additional 3,242 shares during the period. US Bancorp DE bought a new position in Arteris in the 3rd quarter valued at about $34,000. Renaissance Technologies LLC increased its stake in Arteris by 6.1% during the 2nd quarter. Renaissance Technologies LLC now owns 114,700 shares of the company's stock valued at $861,000 after buying an additional 6,600 shares during the period. MetLife Investment Management LLC increased its stake in Arteris by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock valued at $131,000 after buying an additional 9,551 shares during the period. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of Arteris during the 2nd quarter worth about $86,000. 64.36% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Rosenblatt Securities restated a "buy" rating and issued a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.

Arteris Stock Performance

Shares of NASDAQ:AIP traded up $0.15 during trading on Friday, hitting $10.29. 493,195 shares of the company traded hands, compared to its average volume of 166,465. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The business's fifty day moving average is $8.00 and its 200-day moving average is $7.83. The stock has a market capitalization of $413.42 million, a price-to-earnings ratio of -10.72 and a beta of 1.25. Arteris has a one year low of $4.83 and a one year high of $10.60.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.